BIM
OPTR

BlackRock Investment Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

BlackRock Investment Management’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-138,061
Closed -$1.74M – 3475
2013
Q3 		$1.74M Buy
138,061
+9,344
+7% +$124K ﹤0.01% 2053
2013
Q2 		$1.86M Buy
+128,717
New +$1.87M ﹤0.01% 1910

BlackRock Investment Management's OPTR Position: Q4 2013 in Review

BlackRock Investment Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 138,061 shares — an estimated $1.74M sold.

BlackRock Investment Management first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $1.86M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • BlackRock Investment Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • BlackRock Investment Management sold 138,061 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $1.74M.
  • BlackRock Investment Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • BlackRock Investment Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $1.86M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on BlackRock Investment Management's 13F filing for Q4 2013, filed 12 Feb 2014.